- Home
- MRK vs PRA Comparison
MRK vs PRA Comparison
Compare MRK & PRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRK | PRA |
|---|---|---|
| Founded | 2000 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 260.2B | 1.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MRK | PRA |
|---|---|---|
| Price | $101.71 | $24.20 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 3 |
| Target Price | ★ $111.93 | $22.50 |
| AVG Volume (30 Days) | ★ 15.2M | 386.6K |
| Earning Date | 02-03-2026 | 11-04-2025 |
| Dividend Yield | ★ 3.38% | N/A |
| EPS Growth | ★ 58.08 | N/A |
| EPS | ★ 7.56 | 0.66 |
| Revenue | ★ $64,235,000,000.00 | $1,120,385,000.00 |
| Revenue This Year | $1.97 | N/A |
| Revenue Next Year | $4.96 | $1.24 |
| P/E Ratio | ★ $13.33 | $36.81 |
| Revenue Growth | ★ 1.68 | N/A |
| 52 Week Low | $73.31 | $13.90 |
| 52 Week High | $105.84 | $24.41 |
Technical Indicators
Market Signals| Indicator | MRK | PRA |
|---|---|---|
| Relative Strength Index (RSI) | 61.55 | 59.43 |
| Support Level | $96.79 | $24.14 |
| Resistance Level | $100.94 | $24.27 |
| Average True Range (ATR) | 2.30 | 0.09 |
| MACD | -0.41 | 0.02 |
| Stochastic Oscillator | 80.10 | 61.61 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About PRA ProAssurance Corporation
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.